Clinical Study Results
During treatment, the participants stayed at the study site for 12 days. During
this time, they took AZD5718 or the placebo once daily on Day 1 and Days 3 to 10.
This was a total of 9 doses. Each day, the doctors checked the overall health of the
participants, took blood and urine samples, and did ECGs.
The researchers studied the participants’ results after treatment in one group before the
next group started treatment.
7 to 10 days after treatment, the participants returned to the study site. During this
visit, the doctors checked their overall health.
Before treatment During treatment After treatment
Doctors asked about the • 24 participants got • Participants returned to
medical history of AZD5718 at either a 60, the study site 7 to 10 days
participants, took blood and 180, 360, or 600 mg dose. after their last dose for a
urine samples, did an ECG, 8 participants got placebo. follow-up visit.
and did a physical
• Each participant got • Doctors checked the
examination.
9 doses. overall health of
participants.
• Doctors checked the
overall health of the
participants, took blood
and urine samples, and
did ECGs.
• Participants stayed at the
study site.
12 days
What were the results of the study?
This is a summary of the main results from this study overall. The results each
participant had might be different and are not in this summary.
Researchers look at the results of many studies to decide which treatments work best
and are safest. Other studies may provide new information or different results. Always
talk to a doctor before making any treatment change
The websites listed at the end of this summary may have a full report of the study
results.
3